Why the study?
Giant cell myocarditis is a rare, rapidly progressive disease with high mortality, presenting significant diagnostic and management challenges.
Giant cell myocarditis can present with rapid myocardial remodeling and sudden death, highlighting the need for early recognition and aggressive treatment.
Answers are grounded in this paper and cite their sources.
Fatal arrhythmia risk in suspected giant cell myocarditis with massive LV dilation awaiting transplant warrants caution; larger cohorts needed to guide practice.
Giant cell myocarditis is a rare and rapidly progressive disease with a high mortality rate. We present the case of a 21-year-old male without a medical history who presented with a giant left ventricle (9.9 cm, EF:10%) and in a severe clinical state. Cardiac MRI and virology raised the suspicion of giant cell myocarditis. Concerned about the hemodynamic and respiratory deterioration, we initiated cardiac transplant therapy. A fatal ventricular fibrillation occurs while waiting for the heart transplant. Sudden death could represent the "first symptom" of pathological findings. It is important to recognize that while sudden death due to giant cell myocarditis may be rare, it is still a potentially serious complication of giant cell infection and should be considered in cases of unexplained sudden death. In addition, this case highlights the challenges in the diagnosis and management of giant cell myocarditis and the need for early recognition and aggressive treatment.
No takes yet. Share an insight, caveat, or question.
Wei Zhang (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: